Ophthotech

Outcome Health imagewaiting room COVID-19 campaign
Biotech

Iveric latest to be hit by COVID-19 as it delays a key trial

Iveric Bio has been forced to hit the pause button for a pivotal test on its leading drug Zimura as COVID-19 continues to back up clinical trials.
Ben Adams Mar 18, 2020 9:15am
Eye

Ophthotech (now Iveric) hits eye drug goals as shares jump

Oct 28, 2019 8:03am
Eye

Ophthotech becomes Iveric in pivot to gene therapies

Apr 16, 2019 9:55am
close-up of childs green eye

Apellis says timeline still on track for stalled eye drug

Dec 20, 2018 10:39am
blue eye

Ophthotech adds to pipeline again as climb back continues

Oct 31, 2018 12:02pm
Crater

Ophthotech completes clean sweep of phase 3 trial flops

Aug 14, 2017 9:00am